Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Paliperidone

An atypical antipsychotic for schizophrenia, approved in the United States in 2006: it is 9-hydroxyrisperidone, the main active metabolite of risperidone, which became a medicine in its own right. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Bound to palmitic acid it becomes a slow-release injection: in 2021 the United States approved an even longer-acting version.

PaliperidonePharmacopoeial impurityPaliperidoneCat. No. P-P005-074CAS 144598-75-4

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.